We have previously reported on the biological activity of members of a
library of low molecular weight compounds (carriers) that enable the
oral delivery of proteins (Milstein, Proceedings of the 1995 Miami Bio
/Technology Winter Symposium on Protein Engineering and Structural Bio
logy, IRL Press at Oxford Vniversity Press, 1995, p. 13; Leone-Bay et
al., J. Med. Chem. 38 (1995) 4263-4269; Leone-Bay et al., J. Med. Chem
. 39 (1996) 2571-2578; [1-3]). When rats or primates are orally admini
stered a solution of carrier and either recombinant human alpha-interf
eron (rhIFN), insulin or recombinant human growth hormone (rhGH) signi
ficant serum concentrations of the proteins are detectable. The transp
ort activity of these compounds is positively correlated with their st
ructural effects on the protein molecules. Direct measurement of the i
nteraction of these carrier molecules with the proteins indicates that
they reversibly destabilize the native state of the molecule favoring
a partially unfolded conformation. Apparently these intermediate prot
ein conformations are transport competent and are able to be absorbed
through the intestinal tissue and into the bloodstream. Since the meas
ured binding of the carriers to the partially unfolded proteins is rel
atively weak (K-b=100 M-1) and the systemic activity of the proteins a
ppears to be unaffected, the changes in the structure of the proteins
are manifestly reversible. (C) 1998 Elsevier Science B.V.